Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Multiple Myeloma 1Leukemia, Plasma Cell 1Esophageal Neoplasms 1Barrett Esophagus 1Atypical Squamous Cells of the Cervix 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 41Radiotherapy 38Cisplatin 35Oxaliplatin 32Leucovorin 24Paclitaxel 22Irinotecan 20Docetaxel 17Neoadjuvant Therapy 14Carboplatin 13Radiation 12Capecitabine 12Surgical Procedures, Operative 10Cetuximab 8Biopsy 8durvalumab 7Gefitinib 7Chemotherapy, Adjuvant 7tremelimumab 6pembrolizumab 6Nivolumab 6Magnetic Resonance Spectroscopy 6Folfox protocol 6Taxes 5Immunohistochemistry 5Endoscopy 5Gene Expression Profiling 4Epirubicin 4Drug Therapy 4dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma Of Esophagus × High-Throughput Screening Assays × Clear all
NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡